OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS)
Victor Pera, Guy Brusselle, Sebastian Riemann, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Victor Pera, Guy Brusselle, Sebastian Riemann, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Showing 8 citing articles:
Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution
Joyceline De Volder, Annelies Bontinck, Valerie Haelterman, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Joyceline De Volder, Annelies Bontinck, Valerie Haelterman, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Inhibition of EETosis with an anti-citrullinated histone antibody: a novel therapeutic approach for eosinophilic inflammatory disorders
Eline Zwiers, Daphne Montizaan, Annemarie Kip, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Eline Zwiers, Daphne Montizaan, Annemarie Kip, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database
Yongfu Song, Zhuang Wang, Na Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Yongfu Song, Zhuang Wang, Na Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities
Paneez Khoury, Florence Roufosse, Fei Li Kuang, et al.
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 3
Paneez Khoury, Florence Roufosse, Fei Li Kuang, et al.
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 3
A rare case of disseminated amebiasis in a patient on biologic therapy for chronic rhinosinusitis
Ariel Omiunu, Lindsey Brown, Darpan Kayastha, et al.
International Forum of Allergy & Rhinology (2024)
Closed Access | Times Cited: 1
Ariel Omiunu, Lindsey Brown, Darpan Kayastha, et al.
International Forum of Allergy & Rhinology (2024)
Closed Access | Times Cited: 1
Neue Immunsuppressiva und das Risiko opportunistischer Infektionen
Fabian Reinhardt, Amrei von Braun, Henning Trawinski
Arthritis und Rheuma (2024) Vol. 44, Iss. 03, pp. 155-164
Closed Access
Fabian Reinhardt, Amrei von Braun, Henning Trawinski
Arthritis und Rheuma (2024) Vol. 44, Iss. 03, pp. 155-164
Closed Access
Disproportionality analysis of reslizumab based on the FDA Adverse Event Reporting System
Huqun Li, Cuilian Guo, Chongshu Wang
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access
Huqun Li, Cuilian Guo, Chongshu Wang
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned
Diego M. Conti, Vibeke Backer, W.J. Fokkens, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access
Diego M. Conti, Vibeke Backer, W.J. Fokkens, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access
